Evaluation of expanded digitized imaging in VR and AR for cholangiocarcinoma

Recruiting

• Conditions: C22.1; Intrahepatic bile duct carcinoma

• Registration Number: DRKS00022399
• Lead Sponsor: Pius-HospitalMedizinischer Campus Universität Oldenburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Surgeons:
•All surgoens involved in the operational planning and the operation itselfi
•For pretest: Surgeons outside of the core team but the knowledge of the case

Patient:
•Patient with cholangiocarcinoma

Exclusion Criteria

Surgeons:
·Refusal to participate in the study

Patient:
·Refusal to participate in the study

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
sefulness of the new VR and AR methods for the surgeons preoperational planning and during the operation.

Secondary Outcome Measures

Name	Time	Method
sability of the new systems.